Dan Gwak - Profile and Investment Details

Investor Profile

Dan Gwak is a Venture Capital, Private Equity Firm based in Palo Alto, United States with a diverse investment portfolio that includes companies such as Acorns, Praxis Precision Medicines, Spherical Defense, MX Technologies, Imperative Execution, Armorblox, SayAgolo, Caribou Biosciences, DriveWealth, NetraDyne, Ualá, ActZero.ai, Entrada Therapeutics, AlphaFlow, Botkeeper, Hexa, TradeIT, Stellar Health, Fauna, Brace, Abound, Contabilizei, inVia Robotics, Swapp, PolyAI, Apprente, Anvilogic, Bigeye, Deep 6 AI, Productfy, DotAlign, Nav, Credijusto, Toggle, Flybits, Lockstep, Flare, DeepScale, Unravel Data, Pico, MIRROR, Tempo Automation, HANetf, Extend, HelloOffice, Bayzat, Roostify, Quantopian, Unbabel, Vestwell, Mantl, Trade Ledger, Street Contxt, Kindur, Sprout Solutions, Cloud9 Technologies, TONIK, BluBracket, Shield AI, Privacera, ClickSWITCH, . Over time, Dan Gwak has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Dan Gwak is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Genetics, Autonomous Vehicles, E-commerce, Accounting, Cybersecurity, Disruptive Innovation, Wellness, Women Founded, Enterprise Software, Investment Management, Digital Media, HR Tech, Healthcare Innovation, Enterprise Resource Planning (ERP), Life Science, Engineering, Portfolio Management, Banking, Artificial Intelligence (AI), Retail, Robotics, Information Technology (IT), Analytics, Cloud Computing, Geospatial Data, Finance, Software, Manufacturing, Biotechnology, Genomics, Technical Support, Legal Tech, Innovation, Content, FinTech, Disruptive technology, Digital Transformation, Consumer Internet, Consumer Software, Consulting, Marketing, UK Startups, Medical, SaaS, Big Data, Information Technology, B2B, Therapeutics, Digital Assets, Machine Learning, Emergency Medicine, National Security, Healthcare Technology, Risk Management may find it worthwhile to explore potential connections with Dan Gwak, as their portfolio suggests a familiarity and interest in this area.

Understanding Dan Gwak’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.